← Tous les termes
CATÉGORIE: SAFETY SURVEILLANCE

AEMS (Système de surveillance des événements indésirables)

La plateforme unifiée FDA lancée en mars 2026 remplaçant MAUDE, FAERS, VAERS et 4 autres systèmes.

Last reviewed 2026-08-05 · Reviewed by MedFlux Editorial Board · Editorial policy

Expanded process notes below are currently maintained in English; the short definition above is localized. See our editorial policy.

WHEN IT APPLIES

AEMS is FDA’s 2026 unified adverse event platform consolidating legacy systems including MAUDE for devices. RA/quality teams should plan monitoring workflows for the transition.

PROCESS / STEPS

  1. Map current MAUDE/openFDA queries to AEMS capabilities as published.
  2. Update SOPs for searching and archiving AE evidence.
  3. Train teams on timelines and API changes.
  4. Keep dual-monitoring during transition windows.

EXAMPLES

  • Cross-product signals (drug-device) are a stated goal of unified surveillance.

RELATED GUIDES & TOOLS

SOURCES

Track regulatory signals related to AEMS (Système de surveillance des événements indésirables) across 27 authorities in real time.

START FREE →

TERMES CONNEXES

Base de données MAUDEÉvénement indésirableMedWatch